FDA approves deep TMS device for depression
TEL AVIV (Reuters) - Brainsway received U.S. Food and Drug Administration approval for use of its Deep
TMS (transcranial magnetic stimulation) device for the treatment of depression in patients who fail to respond to
medication.
Source: Modern Medicine - Category: Journals (General) Source Type: news